132 related articles for article (PubMed ID: 22810449)
21. Stopping guidelines for an effectiveness trial: what should the protocol specify?
Tyson JE; Pedroza C; Wallace D; D'Angio C; Bell EF; Das A
Trials; 2016 May; 17(1):240. PubMed ID: 27165260
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity analyses assessing the impact of early stopping on systematic reviews: Recommendations for interpreting guidelines.
Marschner IC; Askie LM; Schou IM
Res Synth Methods; 2020 Mar; 11(2):287-300. PubMed ID: 31901013
[TBL] [Abstract][Full Text] [Related]
23. Issues in clinical trial design: stopping a trial early and the large and simple trial.
Thom EA; Klebanoff MA
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):619-25. PubMed ID: 16150252
[TBL] [Abstract][Full Text] [Related]
24. Systematic reviewers neglect bias that results from trials stopped early for benefit.
Bassler D; Ferreira-Gonzalez I; Briel M; Cook DJ; Devereaux PJ; Heels-Ansdell D; Kirpalani H; Meade MO; Montori VM; Rozenberg A; Schünemann HJ; Guyatt GH
J Clin Epidemiol; 2007 Sep; 60(9):869-73. PubMed ID: 17689802
[TBL] [Abstract][Full Text] [Related]
25. Ethical issues in stopping randomized trials early because of apparent benefit.
Mueller PS; Montori VM; Bassler D; Koenig BA; Guyatt GH
Ann Intern Med; 2007 Jun; 146(12):878-81. PubMed ID: 17577007
[TBL] [Abstract][Full Text] [Related]
26. Pro/con clinical debate: It is acceptable to stop large multicentre randomized controlled trials at interim analysis for futility. Pro: Futility stopping can speed up the development of effective treatments.
Schoenfeld DA
Crit Care; 2005 Feb; 9(1):34-6; discussion 34-6. PubMed ID: 15693981
[TBL] [Abstract][Full Text] [Related]
27. Stopping or reporting early for positive results in randomized clinical trials: the National Cancer Institute Cooperative Group experience from 1990 to 2005.
Korn EL; Freidlin B; Mooney M
J Clin Oncol; 2009 Apr; 27(10):1712-21. PubMed ID: 19237631
[TBL] [Abstract][Full Text] [Related]
28. Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands.
van den Bogert CA; Souverein PC; Brekelmans CTM; Janssen SWJ; Koëter GH; Leufkens HGM; Bouter LM
J Clin Epidemiol; 2017 Aug; 88():140-147. PubMed ID: 28487159
[TBL] [Abstract][Full Text] [Related]
29. Interpretation of Clinical Trials That Stopped Early.
Viele K; McGlothlin A; Broglio K
JAMA; 2016 Apr; 315(15):1646-7. PubMed ID: 27092832
[No Abstract] [Full Text] [Related]
30. Current controversies in data monitoring for clinical trials.
Pocock SJ
Clin Trials; 2006; 3(6):513-21. PubMed ID: 17170035
[TBL] [Abstract][Full Text] [Related]
31. Accounting for interim safety monitoring of an adverse event upon termination of a clinical trial.
Dallas MJ
J Biopharm Stat; 2008; 18(4):631-8; discussion 439-45. PubMed ID: 18607795
[TBL] [Abstract][Full Text] [Related]
32. Stopping clinical trials because of treatment ineffectiveness: a comparison of a futility design with a method of stochastic curtailment.
Whitehead J; Matsushita T
Stat Med; 2003 Mar; 22(5):677-87. PubMed ID: 12587099
[TBL] [Abstract][Full Text] [Related]
33. Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information. Part 4: One method.
Ball G
Contemp Clin Trials; 2011 Sep; 32 Suppl 1():S11-7. PubMed ID: 21651993
[TBL] [Abstract][Full Text] [Related]
34. Overestimation of benefit when clinical trials stop early: a simulation study.
Liu S; Garrison SR
Trials; 2022 Sep; 23(1):747. PubMed ID: 36064448
[TBL] [Abstract][Full Text] [Related]
35. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
Zhao Y; Grambsch PM; Neaton JD
Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
[TBL] [Abstract][Full Text] [Related]
36. Ethical pitfalls in neonatal comparative effectiveness trials.
Modi N
Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
[TBL] [Abstract][Full Text] [Related]
37. The early termination of clinical trials: causes, consequences, and control. With special reference to trials in the field of arrhythmias and sudden death. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
Circulation; 1994 Jun; 89(6):2892-907. PubMed ID: 8205706
[TBL] [Abstract][Full Text] [Related]
38. Continuous safety monitoring for randomized controlled clinical trials.
Piller LB; Silverman MH; Ball G
Contemp Clin Trials; 2011 Sep; 32 Suppl 1():S1. PubMed ID: 21458597
[No Abstract] [Full Text] [Related]
39. How reliable are clinical trials? The importance of the criteria for early termination.
Schwartz PJ
Eur Heart J; 1995 Aug; 16 Suppl G():37-45. PubMed ID: 8595799
[TBL] [Abstract][Full Text] [Related]
40. Randomised controlled trials in oncology closed early for benefit: trends in methodology, results, and interpretation.
Booth CM; Ohorodnyk P; Zhu L; Tu D; Meyer RM
Eur J Cancer; 2011 Apr; 47(6):854-63. PubMed ID: 21296570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
